You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Adjuvant

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cervical Cancer Trial in Suzhou (Chemoradiotherapy + Adjuvant chemo and Zimberelimab, Chemoradiotherapy (small pelvic) +

Recruiting
  • Cervical Cancer
  • Chemoradiotherapy + Adjuvant chemotherapy and Zimberelimab
  • Chemoradiotherapy (small pelvic) + Zimberelimab
  • Suzhou, Jiangsu, China
    The Affiliated Suzhou Hospital of Nanjing Medical University
May 14, 2023

Endometrial Carcinoma Trial in Sohag (Paclitaxel/epirubcin/carboplatin, Paclitaxel/carboplatin)

Not yet recruiting
  • Endometrial Carcinoma
  • Sohag, Egypt
    Sohag university Hospital
Oct 25, 2023

Breast Cancer With Liposomal Doxorubicin Regimen

Recruiting
  • Breast Cancer
  • +4 more
  • Liposomal doxorubicin containing regimen
  • Hangzhou, Zhejiang, China
    Second Affiliate Hospital of Zhejiang University
Feb 7, 2023

Pancreas Cancer, Pancreas Adenocarcinoma Trial in Cleveland (Capecitabine)

Not yet recruiting
  • Pancreas Cancer
  • Pancreas Adenocarcinoma
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Seidman Cancer Ce
Oct 29, 2023

Vitamin D on Hashimoto's Thyroiditis

Not yet recruiting
  • Hashimoto Thyroiditis
  • Vitamin D Drops
  • (no location specified)
May 22, 2023

Gastrointestinal Tumors, Immunonutrition, Postoperative Adjuvant Chemo Trial in Shenyang (Immunonutrition (Su yusu),

Recruiting
  • Gastrointestinal Tumors
  • +2 more
  • Immunonutrition （Su yusu)
  • fluorouracil based chemotherapy regimens
  • Shenyang, Liaoning, China
    The First Hospital of China Medical University
Oct 13, 2023

Uveal Melanoma Trial in Grand Rapids (Darovasertib)

Recruiting
  • Uveal Melanoma
  • Grand Rapids, Michigan
    The Cancer and Hematology Centers
Jun 14, 2023

Toxicity Trial in Ghent (Adjuvant EBRT)

Completed
  • Toxicity
  • Adjuvant EBRT
  • Ghent, Belgium
    Dept of Radiotherapy, University Hospital Ghent
Dec 23, 2022

Breast Cancer Trial (Ovarian Function Suppression + Aromatase Inhibitor, Adjuvant Chemotherapy + Ovarian Function Suppression)

Not yet recruiting
  • Breast Cancer
  • Ovarian Function Suppression + Aromatase Inhibitor
  • Adjuvant Chemotherapy + Ovarian Function Suppression
  • (no location specified)
May 19, 2023

Pain, Postoperative Trial in Cleveland (IV Magnesium Sulfate)

Not yet recruiting
  • Pain, Postoperative
  • IV Magnesium Sulfate
  • Cleveland, Ohio
    University Hospitals
Jul 5, 2023

Resectable Pancreatic Cancer, Ductal Adenocarcinoma of the Pancreas Trial in Ulm (perioperative nab-paclitaxel/gemcitabine,

Completed
  • Resectable Pancreatic Cancer
  • Ductal Adenocarcinoma of the Pancreas
  • perioperative nab-paclitaxel/gemcitabine
  • adjuvant nab-paclitaxel/gemcitabine
  • Ulm, Germany
    University of Ulm, Dept. of Internal Medicine I
Nov 21, 2022

Renal Cell Carcinoma Trial in Birmingham (Pembrolizumab injection)

Not yet recruiting
  • Renal Cell Carcinoma
  • Pembrolizumab injection
  • Birmingham, Alabama
    University of Alabama at Birmingham
Aug 20, 2023

Magnesium, Intraoperative Analgesia Trial (Magnesium Sulfate, Propofol)

Not yet recruiting
  • Magnesium
  • Intraoperative Analgesia
  • (no location specified)
Nov 12, 2023

Colorectal Cancer, Chemo Effect Trial in GuangZhou (FOLFOX chemo regimens, Bevacizumab)

Not yet recruiting
  • Colorectal Cancer
  • Chemotherapy Effect
  • GuangZhou, Guangdong, China
    The Sixth Affiliate Hospital of Sun Yat-Sen University
Apr 3, 2023

Adjuvant Immune Checkpoint Inhibitors in Postoperative

Recruiting
  • Hepatocellular Carcinoma
  • Immune Checkpoint Inhibitors Based Adjuvant therapy
  • Nanning, Guangxi, China
    Jian-Hong Zhong
Jan 18, 2023

Stage II-IIIB(N2) NSCLC Trial in Shanghai (TQB2450, Carboplatin, Pemetrexed)

Not yet recruiting
  • Stage II-IIIB(N2) Non-small Cell Lung Cancer
  • Shanghai, Shanghai, China
    Shanghai Pulmonary Hospital
Oct 26, 2023

Hepatocellular Carcinoma Trial in Wuhan (Sintilimab, Transarterial Chemoembolization (TACE))

Not yet recruiting
  • Hepatocellular Carcinoma
  • Sintilimab
  • Transarterial Chemoembolization (TACE)
  • Wuhan, Hubei, China
    Tongji Hospital, Tongji Medical College, Huazhong University of
Oct 17, 2023

Transversus Abdominis Plane Block Trial in Van (Dexmedetomidin + bupivacaine, Tramadol + Bupivacaine)

Completed
  • Transversus Abdominis Plane Block
  • Dexmedetomidin + bupivacaine
  • Tramadol + Bupivacaine
  • Van, Turkey
    Van Yuzuncu Yil University
Jun 14, 2023

Validation Trial in Amares (Control group, Experimental group)

Recruiting
  • Validation
  • Control group
  • Experimental group
  • Amares, Braga, Portugal
    ISAVE
Jul 30, 2023

Chemotherapy Alone Versus Chemotherapy Plus Targeted Therapy as

Completed
  • Colorectal Cancer Metastatic
  • Targeted agent
  • (no location specified)
Aug 31, 2023

Vulvar HSIL, HPV Trial in Rotterdam (Gardasil 9 Suspension for Injection, Placebo)

Not yet recruiting
  • Vulvar HSIL
  • HPV
  • Gardasil 9 Suspension for Injection
  • Placebo
  • Rotterdam, Netherlands
    Erasmus MC
Sep 21, 2023

Liver Tumors Trial in Beijing (Tislelizumab plus tyrosine kinase inhibitor)

Recruiting
  • Liver Neoplasms
  • Tislelizumab plus tyrosine kinase inhibitor
  • Beijing, Beijing, China
    302 Hospital
Sep 22, 2023

Esophageal Cancer, Surgery, Neoadjuvant Treatment Trial in Zhengzhou (Neoadjuvant immunochemo)

Recruiting
  • Esophageal Cancer
  • +3 more
  • Neoadjuvant immunochemotherapy
  • Zhengzhou, Henan, China
    Henan Cancer Hospital (The Affiliated Cancer Hospital of Zhengzh
Oct 2, 2022

Dexmedetomidine as an Adjuvant to Quadratus Lumborum Block

Completed
  • Pain, Postoperative
    • Istanbul, Please Select, Turkey
      PINAR Kendigelen
    Jul 29, 2023

    Colo-rectal Cancer Trial in Beijing (adjuvant therapy based on 3D drug sensitivity test results of micro tumor (PTC) in vitro)

    Recruiting
    • Colo-rectal Cancer
    • adjuvant therapy based on 3D drug sensitivity test results of micro tumor (PTC) in vitro
    • Beijing, China/Beijing, China
      Peking Union Medical College Hospital, Chinese Academy of Medici
    Aug 4, 2023